Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Amgen Inc. (AMGN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Amgen Inc. (AMGN), most recent 12 months reported: revenue $38.09B, net income $8.74B, free cash flow $10.18B. Latest balance sheet on file: liquid cash $13.99B, total debt $57.3B, net cash -$43.31B. From SEC filings. More on Amgen Inc.: Revenue · Profitability · Cash flow · Debt · Dividends Others in Biological Products, (No Diagnostic Substances): GILEAD SCIENCES, INC. · BIOGEN INC. · NEUROCRINE BIOSCIENCES INC · Exelixis Inc · Moderna, Inc. · QIAGEN N.V. · HALOZYME THERAPEUTICS, INC. · BIO-TECHNE Corp

Stock screener

Watchlist